- Home
- Neurosurgery
- Galcanezumab for Chronic Migraine Prevention: Clinical Insights from REGAIN Study
1mo3 min read
Medical Article
Introduction: Chronic migraine (CM) is a disabling neurological condition characterized by ≥15 headache days per month, with ≥8 days meeting criteria for migraine (1). Compared to episodic migraine, CM is associated with greater disability, higher rates of comorbid medical and psychiatric conditions, and increased healthcare resource utilization (1

Galcanezumab for Chronic Migraine Prevention: Clinical Insights from REGAIN Study
1 Reached
Similar Content

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Neurotrophic Deep Corneal Ulcer in Old Male
1139 Reached5 Comments4 Likes

Physical Therapy for Individuals with Tremors
504 Reached9 Comments5 Likes

Cognitive Effects of OnabotulinumtoxinA in Chronic Migraine
7184 Reached4 Comments
